First effort to review newly-released EUA documents (Source: search for `eua` at https://phmpt.org) 

### Data Visualization of Tags (and file picker)
1. Download the CSV from this repository
2. Visit https://mroswell.github.io/eua-review
3. Upload the csv file that has used AI to tag the first 7 pages of each document
4. Click on a tag name or bar to access the files that were given those tags.

### Data Dictionary

https://mroswell.github.io/eua-review/data-dictionary.html

### Related Documentation that can provide insight into data variables
- Study Data Tabulation Model: https://www.cdisc.org/system/files/members/standard/foundational/SDTM_v2.0.pdf
- Analysis Data Reviewer Guide - BLA Analysis for Participants ≥16 Years of Age BioNTech SE and PFIZER INC.
Study C4591001: https://phmpt.org/wp-content/uploads/2022/03/125742_S1_M5_c4591001-A-adrg.pdf
- Analysis Data Reviewer’s Guide - ModernaTX, Inc. Study mRNA-1273-P201 Part A: https://phmpt.org/wp-content/uploads/2025/05/125752_S3_M5_mrna-1273-p201-add1_A_D_adrg.pdf
- https://phmpt.org/wp-content/uploads/2022/05/125742_S1_M5_bnt162-01-A-adrg.pdf
- https://rpodcast.quarto.pub/pilot4-webassembly-adrg/
- Create addv dataset (SAS) https://phmpt.org/wp-content/uploads/2023/09/125742-45_S211_M5_c4591001-A_1mth-P-addv-sas.pdf
- Create adsl dataset (SAS): https://phmpt.org/wp-content/uploads/2022/03/FDA-CBER-2021-5683-0022867-to-0023006_125742_S1_M5_c4591001-A-P-adsl-sas.txt
-  Create adc19ef-ve-cov-7pd2-wo-sg-eval (SAS): https://phmpt.org/wp-content/uploads/2022/03/FDA-CBER-2021-5683-0022041-to-0022053_125742_S1_M5_c4591001-A-P-adc19ef-ve-cov-7pd2-wo-sg-eval-sas.txt
- https://phmpt.org/wp-content/uploads/2022/03/FDA-CBER-2021-5683-0022041-to-0022053_125742_S1_M5_c4591001-A-P-adc19ef-ve-cov-7pd2-wo-sg-eval-sas.txt
- create admh dataset (SAS) https://icandecide.org/wp-content/uploads/2022/03/FDA-CBER-2021-5683-0022601-to-0022617_125742_S1_M5_c4591001-A-P-admh-sas.txt
- SDTM Variables You Might Forget About: https://pharmasug.org/proceedings/2023/DS/PharmaSUG-2023-DS-054.pdf
- Practical Guide to Creating ADaM Datasets for Cross-over Studies: https://www.lexjansen.com/pharmasug/2019/DS/PharmaSUG-2019-DS-196.pdf
- CDISC Standards RDF REference Guide Final https://www.cdisc.org/system/files/members/standard/foundational/rdf/CDISC%20Standards%20RDF%20Reference%20Guide%201.0%20Final%202015-06-18.pdf
- Analysis of Adverse EVEnts: https://leg.colorado.gov/sites/default/files/html-attachments/h_bus_2022a_03032022_013716_pm_committee_summary/Attachment%20C.pdf
- https://dctd.cancer.gov/research/ctep-trials/trial-development
- SAP - https://cdn.clinicaltrials.gov/large-docs/28/NCT04368728/SAP_001.pdf

In clinical trial submissions to regulatory authorities (like the FDA, EMA, or other agencies), the content is organized into a standardized format called the Common Technical Document (CTD). Here are the five modules:

**Module 1: Administrative Information and Prescribing Information**
- Region-specific administrative documents
- Application forms, cover letters
- Proposed labeling/prescribing information
- Patent information
- Field copy certifications
- This module varies by regulatory authority (not harmonized)

**Module 2: CTD Summaries**
- High-level overviews of the entire submission
- Contains:
  - CTD Table of Contents
  - CTD Introduction
  - Quality Overall Summary (QOS)
  - Nonclinical Overview and Summaries
  - Clinical Overview and Summaries
- Written by experts to provide regulators with a comprehensive summary

**Module 3: Quality (CMC - Chemistry, Manufacturing, and Controls)**
- Drug substance information (active ingredient)
- Drug product information (finished formulation)
- Manufacturing processes and controls
- Specifications and analytical methods
- Stability data
- Container closure systems
- Essentially all pharmaceutical development and manufacturing information

**Module 4: Nonclinical Study Reports**
- Pharmacology studies (primary, secondary, safety)
- Pharmacokinetics (ADME - absorption, distribution, metabolism, excretion)
- Toxicology studies (single dose, repeat dose, reproductive, carcinogenicity)
- All animal and laboratory studies
- Written and tabulated summaries of nonclinical data

**Module 5: Clinical Study Reports**
- All human clinical trial data
- Biopharmaceutic studies
- Pharmacokinetic studies in humans
- Pharmacodynamic studies
- Efficacy and safety studies (Phase 1, 2, 3)
- Post-marketing experience (if applicable)
- Case report forms and individual patient listings

